title: High-dose recombinant interleukin-2/verapamil combination in advanced cancer.
authors.forename: P
authors.initials: P
authors.lastname: Tagliaferri
authors.forename: P
authors.initials: P
authors.lastname: Correale
authors.forename: M
authors.initials: M
authors.lastname: Mottola
authors.forename: G
authors.initials: G
authors.lastname: de Simone
authors.forename: V
authors.initials: V
authors.lastname: Montesarchio
authors.forename: E
authors.initials: E
authors.lastname: Matano
authors.forename: A
authors.initials: A
authors.lastname: Rea
authors.forename: A
authors.initials: A
authors.lastname: Morabito
authors.forename: M
authors.initials: M
authors.lastname: Famiani
authors.forename: F
authors.initials: F
authors.lastname: Ciardiello
authors.forename: G
authors.initials: G
authors.lastname: Tortora
authors.forename: M
authors.initials: M
authors.lastname: Caraglia
authors.forename: C
authors.initials: C
authors.lastname: Barile
authors.forename: G
authors.initials: G
authors.lastname: Palmieri
authors.forename: A R
authors.initials: AR
authors.lastname: Bianco
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D002121:Calcium Channel Blockers; D007376:Interleukin-2; D011994:Recombinant Proteins; D014700:Verapamil